Gyre Therapeutics (GYRE) Receivables - Other (2012 - 2026)
Gyre Therapeutics' Receivables - Other was $255,000 in Q2 2026, up 10.9% from $230,000 a year earlier and up 10.9% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Receivables - Other (2012 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Other at Gyre Therapeutics came in at $230,000, down 95.4% from FY2024.
- In earlier years, Receivables - Other was $4.96 million in FY2024 (+281.6%) and $1.3 million in FY2023.
- The Q2 2026 figure marks the highest quarterly Receivables - Other since Q4 2024.
- Compared with a year earlier, Receivables - Other was higher in three of the last eight quarters, with an average decline of 5.3%.
- The best year-over-year quarter for Receivables - Other over five years was Q2 2024 (growth of 333.3%); the worst was Q4 2025 (a decline of 96.0%).
- Per Business Quant data, GYRE's Receivables - Other in the three quarters before Q2 2026 was $230,000 (Q1 2026), $200,000 (Q4 2025) and $230,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 255,000.00 |
| Mar 31, 2026 | 230,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 230,000.00 |
| Jun 30, 2025 | 230,000.00 |
| Mar 31, 2025 | 230,000.00 |
| Dec 31, 2024 | 4.96 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 300,000.00 |
| Dec 31, 2014 | 13,000.00 |
| Dec 31, 2013 | 183,000.00 |
| Sep 30, 2013 | 32,000.00 |
| Dec 31, 2012 | 1.05 Mn |
API Access
Gyre Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();